Study Design. A nonrandomized, prospective, and singlecenter clinical trial of the ProDisc Vivo prosthesis. Objective. The aim of this study was to investigate the clinical and radiological results of a refined total cervical disc replacement (cTDR), the ProDisc Vivo, with two years of follow-up (FU). The incidence of implant-related complications was recorded as a secondary outcome variable. Summary of Background Data. Previous generations of the ProDisc artificial cervical disc replacement generate high primary stability due to keel-based designs with opening of the anterior cortex during the implantation and subsequent high rates of heterotopic ossifications. Methods. Clinical outcome scores included the Neck Disability Index (NDI), Visual Analogue Scale (VAS), arm and neck pain self-assessment questionnaires. The radiological outcome included the range of motion (ROM) and the occurrence of heterotopic ossifications. The incidence of implant-related complications with new implant design was recorded as a secondary outcome variable. Results. A total of 55 patients received a single-level treatment with the ProDisc Vivo cTDR between C3/4 and C6/7, with a follow-up rate of 78%. The clinical outcome scores improved in all parameters significantly (P ¼ 0.0001) (NDI: 68.3 ! 17.4; VAS arm: 6.3 ! 1.4; VAS neck: 4.9 ! 1.6). The ROM of the indexsegment did not show a significant change (P ¼ 0.26) (7.98 ! 9.28). Heterotopic ossifications at the index segment was found as grade 0 in 58%, grade 1 in 22%, grade 2 in 10%, grade 3 (with functional impairment of the prosthesis) in 7%, and grade 4 in 3% of the cases. We observed three implant-related complications (5.5%), with two implant dislocations anteriorly and one low-grade infect. Conclusion. cTDR with ProDisc Vivo demonstrated a significant and sustained improvement of all clinical outcome parameters. A less invasive implantation mechanism with lower primary stability of the cTDR might be a reason for a higher dislocation rate than the keel-based previous generation ProDisc C.
T otal cervical disc replacement (cTDR) has been established as a viable treatment option for a variety of pathologies, such as symptomatic cervical disc disease or soft disc herniation with radiculopathy. Clinical studies have demonstrated this procedure to be a safe and suitable treatment alternative to the gold standard, anterior cervical discectomy and fusion (ACDF). [1] [2] [3] [4] [5] [6] [7] [8] [9] Since the first introduction of cTDRs, design characteristics and material being used have undergone extensive changes. Initial designs were created with a focus on ensuring primary stability, but employed extensive fixations with screws (e.g., PrestigeST; Medtronic Sofamor Danek, Memphis, TN) or required excessive preparation of the implant site (Bryan Disc; Medtronic Sofamor Danek, Memphis, TN). These designs resulted in technically demanding, time-consuming implantation processes and bared a risk for heterotopic ossifications (HOs) due to opening of the cortical structures. 10, 11 Thus, subsequent cTDR designs aimed to simplify the implantation while circumventing the need to open the cortical structures. Furthermore, The ProDisc Vivo (DePuy Synthes, West Chester, PA) consists of two titanium alloy endplates for improved MRI compatibility and a fixed, ultra-high molecular weight polyethylene (UHMWPE) core on cobalt-chrome-molybdenum alloy articulation, which provides motion in all axes in a semi-constrained fashion for flexion/extension and lateral bending. Primary stability is provided with teeth fixation at each endplate. The superior plate has a convex design for better anatomical fixation as demonstrated in Figure 1 . A trapezoidal footprint design should provide optimal anatomical fit and maximum endplate coverage. Long-term stability is provided by a plasma-sprayed titanium surface, which is intended to promote secondary bony ingrowth.
The aim of this study was to verify the clinical effectiveness of the third design generation of the ProDisc, the ProDisc Vivo, with 2 years follow-up (FU) and to evaluate their radiologic outcome, including implant specific complications.
MATERIALS AND METHODS

Study Design
Within the framework of a prospective, nonrandomized study at a single large spine center, all patients who were treated on a single level between C3 and C7 with a ProDisc Vivo artificial disc prosthesis between March 2012 and March 2015 were consecutively included in this study following their written consent. The investigation included preoperative data as well as 3, 12, and 24 months FU results and was approved by the internal ethics committee.
The inclusion and exclusion criteria of this study were clearly defined before the initiation of this study (Table 1) . Primary inclusion criteria included cervical degenerative disc disease and clinical symptoms of nerve root compression associated with intractable radiculopathy with and without neurological deficits between the levels C3/4 and C6/7, which had proven unresponsive to nonoperative treatment.
Clinical and socioeconomic outcome parameters were determined by means of self-assessment questionnaires that were completed by all patients individually: NDI (Neck Disability Index), VAS (Visual Analog Score) arm pain, and VAS neck pain. Standardized questions relating to patient satisfaction and employment status were likewise completed at each time point.
Radiological examinations entailed X-ray images of the cervical spine in two planes as well as flexion/extension images. Measurements of the prosthesis range of motion (ROM) as well as of the adjacent segments disc space heights were performed with Impax software (Impax EE Software; Agfa Healthcare N.V., Mortsel, Belgium).
The extent of HOs was graded according to the modified McAfee classification system for lumbar disc prostheses as previously described by Mehren et al. (Table 2 ). 
Implant and Surgical Technique
The ProDisc Vivo implant, which was used exclusively in this study, is the third generation of a metal-on-polyethylene, ball-and-socket type articulating device. The implant was inserted en-bloc as a one-piece device. A right-sided anterolateral, microsurgically modified approach was routinely used as previously described. 14 The discectomy and decompression of the spinal canal was performed with the assistance of a surgical microscope.
The midline was marked under anteroposterior (AP) fluoroscopy. The segment was held in distraction by retaining screws. A trial implant with the appropriate footprint and height was adequately placed in the intervertebral space, which was followed by the final insertion of the device into the prepared disc space. Bone wax was used to seal the holes of the retaining screws. In postoperative care, a soft collar was used until wound healing was completed. Nonsteroidal anti-inflammatory medication was not used routinely.
Statistical Analysis
Data consistency was checked and data were screened for outliers and normality by using quantile plots. Pearson Chisquare test was used to analyze crosstabulations tables. A repeated-measures analysis of variance (ANOVA) model with paired Student t tests as post-hoc tests were used to compare means over time. Whisker plots with 95% confidence intervals were used to illustrate results. Pearson correlation coefficients were computed and tested. All tests were performed two-sided, and P values <0.05 were considered as statistically significant. All statistical analyses in this report were performed by use of STATISTICA 13 (Hill, T. & Lewicki, P. Statistics: Methods and Applications; StatSoft, Tulsa, OK).
RESULTS
Patient Characteristics
A total of 55 patients met the inclusion criteria for a singlelevel treatment between C3/4 and C6/7. The average age of included patients was 44.2 years (range 30-62 years) with relatively equal gender distribution (31f, 24m). Treated levels are outlined in Table 3 . The FU rate at the 2 years FU was 78.2% (n ¼ 43).
Clinical Outcome Scores
Mean NDI improved significantly over the study duration, from 68.3 AE 11.0 points preoperatively to 24.4 AE 12.4 points at 12 months (P < 0.0001) and 17.4 AE 11.4 points at 24 months FU (P < 0.0001). The improvement between 12 and 24 months FU was also statistically significant (P < 0.0001) (Figure 2) .
Similarly, VAS arm and VAS neck pain also improved over the course of the observation period from a preoperative mean of 6.3 AE 1.9 and 4.9 AE 2.3 to 1.8 AE 0.9 and 1.8 AE 1.1 at the 12 months and 1.4 AE 0.9 ( Figure 3 ) and 1.6 AE 1.0 (Figure 4) , respectively, at the 24 months FU (P < 0.00001). In contrast to the NDI, no significant difference was observed between 12 and 24 months FU (P ¼ 0.09, P ¼ 0.36, respectively). This improvement of VAS and NDI during the postoperative course was reflected by high patient satisfaction rates: 93% (n ¼ 40/43) of patients reported a highly satisfactory outcome at the 24 months FU examination and 2.3% (n ¼ 1/43) a satisfactory outcome. One of the remaining patients was not satisfied and the other patient did not wish to provide this subjective outcome evaluation.
Radiological Findings
The index segment revealed a preoperative mean ROM of 7.98 AE 4.58. During the subsequent postoperative course, the ROM increased to 9.68 AE 5.38 and 9.28 AE 4.68 in mean at the 12 and 24 months FU examination, respectively ( Figure 5 ). This change in the mean ROM of the index segment was statistically not significant (P ¼ 0.23).
The incidence and severity of HO at the 24 months FU is outlined in Figure 6 : Grade 0 ossification was observed in 58%, grade 1 in 22%, grade 2 in 10%, grade 3 (with functional impairment of the prosthesis) in 7% of cases, and grade 4 (with solid fusion of the index segment) in 3% of cases.
The occurrence of HO did not significantly affect the clinical outcome at the last FU (NDI: P ¼ 0.989; VAS arm: P ¼ 0.417; VAS neck: P ¼ 0.859).
Complications
Dislocation of the whole implant anteriorly was observed in two C3/C4-treated cases. One patient had to be revised within the first postoperative week, necessitating implant removal and interbody fusion with a cage as demonstrated in Figure 7 . The other implant dislocation was observed at the 3 months FU. Although the indication for revision was given, the patient denied any further intervention and was lost to FU.
Another patient presented with persisting neck pain and signs of severe osteolysis [computed tomography (CT) scans], indicating low-grade infection, and was revised after the 12 months FU. After implant removal and fusion with a Figure 3 . Improvement of Visual Analog Scale (VAS) for arm pain over time, illustrated as Whisker plots with 95% confidence intervals. cage, the histological investigation confirmed bacterial infection. Neck pain improved after the revision surgery.
DISCUSSION
The effectiveness of cTDRs has been under investigation for many years. Numerous studies have demonstrated that cTDR and ACDF achieved comparatively similar improvements in clinical outcome parameters, 3, 4, 6, 8, 9, 15 which was confirmed by a systematic review that investigated disability, pain, general state of health, neurological success, and satisfaction. 16 Importantly, a number of studies demonstrated that at short-and mid-term FUs, the rates of postoperative revision surgeries were significantly lower for cTDRs than for ACDFs. 3, 5, 17, 18 Over the years, numerous cTDR designs have been developed, with the goal to facilitate the implantation while obtaining sufficient primary stability. Independent of the type and design of the prosthesis, reports consistently describe a significant improvement of the clinical parameter over time, 8,18 -23 even at longer FUs. 2, 4, 17, 24, 25 The herein presented first report on the outcomes of the Prodisc Vivo is hence in line with previous reports on other cTDRs, with a significant improvement of NDI, VAS arm, and VAS neck at all postoperative stages in comparison to baseline levels. Although clinical parameters constitute the primary readout after cTDR, the measurement of ROM can provide valuable information on functionality. However, up to now, there is no consensus about the ''needed'' ROM to provide a load-sharing function to the adjacent segment. Within this cohort, we observed a nonsignificant increase of ROM of the index segment from 7.98 preoperatively to 9.68 and 9.28 at 12 and 24 months FU, respectively. In the literature, comparable values can be found for other prosthesis designs. Coric et al. 19 reported an increase of ROM from 8.28 (preoperatively) to 9.88 (2-year FU) for another keel-based device, the Kineflex C. Further examples of the ROM at 2 years FU are 7.78 for the Prestige ST, 26 7.98 for the Discover, 27 108 for the Mobi-C, 18 and 8.48 for the ProDisc C 20 and at a slightly lower range, 6.58 for the Bryan Disc 21 and 5.78 for the PCM, 28 but still the radiological success rate with an implant ROM in flexion and extension with more than 28 was indicated with 98.9%.
Despite overall good outcomes of cTDRs, including the ProDisc Vivo (as demonstrated herein), certain complications may arise. These are closely related to the implantation mechanism and the primary stability features of the device. Only a few case reports exist that describe vertebral split fractures after keel-based cTDR, 19, 29, 30 but with less invasive fixation mechanisms, the risk should be lower. The ''non-keel'' ProDisc Vivo provides the primary stability with anatomically configurated endplates and six spikes at each endplate. In fact, no such cases of vertebral split fractures occurred in this cohort, neither immediately nor during the FU. However, we were faced with two (3.6%) early anterior implant dislocations (both in the segment C3/C4), likely due to insufficient posterior preparation/release in combination with initial too far anterior positioning of the device. Despite being a non-keel device, these rates are only slightly higher than for typical keel-based TDRs used in comparable cohorts with similar inclusion criteria, such as the Kineflex-C (2 of 136 at 2 years FU) 19 or the first generation of the ProDisc design, the ProDisc C with zero of 103 at 5 years FU, and 1 of 70 at 10 years FU. 24, 31 Burkus et al. 2 reported about one implant dislocation of 256 Prestige ST prosthesis with an additional anterior transcortical fixation mechanism. Typically, higher rates of implant dislocation even in short-term FU are reported for non-keel based/short teeth fixation designed devices. For example, Shi et al. 27 reported for the Discover prosthesis, used in single-level cases as well, an implant migration in 10 of 60 (16.7%) implanted levels, with an additional two cases (3.3%) with implant subsidence. In summary, the risk of implant subsidence and implant migration seemed to be slightly higher for the devices without an additional anterior or vertebral fixation mechanism (i.e., for non-keel devices) even in the short-term FU. Nevertheless, a sufficient posterior release with resection of the posterior longitudinal ligament and physiological opening of the intervertebral disc space without pathological segmental lordosis and a proper implant positioning in combination with an adequate implant footprint is definitely essential to prevent anterior migration.
Aside from implant dislocation, high-grade HO at the index segment (up to solid fusion, i.e., Grade 4) constitutes an important unintended outcome of cTDRs, affecting the motion and possibly resulting in loss of function of the implanted device. [32] [33] [34] Different cTDR designs were shown to result in different HO rates: Yi et al. 35 compared the keelbased first generation of the ProDisc (ProDisc C) with the Bryan Disc and found HO rates of 71.4% (n ¼ 28) and 21.0% (n ¼ 81) at 12 months FU, respectively; Mehren et al. 13 reported comparable high numbers for the ProDisc C. Other keel-based prosthesis also showed a relatively high incidence of HO, such as 23.8% (Grade 3 and 4) for the Mobi-C cervical disc prosthesis after 4 years FU, with progression over time. 18 However, HO rates seem to be generally lower for designs that abstain from opening of the anterior cortex or extensive graft bed preparation during the implantation procedure. The PCM total disc prostheses demonstrated Grade 3 HO rates of only 3.3% and Grade 4 HO rates of only 1.1% after 2 years FU. 28 In the herein presented cohort operated with the ProDisc Vivo, 7% showed Grade 3 HO and 3% Grade 4 HO after 2 years. Although further studies with comparable cohorts, comparable FUs, diagnostics (X-ray or CT scan), and postoperative care are needed to verify these findings, our data support the postulated hypothesis that HO occurrence may be related to the preparation of the end plates as well as the opening of the cortex.
10,11
Study Limitations
One of the limitations of this present investigation is a potential selection bias, which may be attributed to the fact that the data are derived from a nonrandomized case series. In addition, a longer FU is needed to capture the rate of implant-loosening due to insufficient ingrowth of the device.
CONCLUSION
We herein present the first study evaluating the clinical and radiological outcome of ProDisc Vivo, a novel cTDR. Similar to other cTDRs, the ProDisc Vivo device demonstrated a high clinical success-rate during the 2 years FU. The absence of keels in the ProDisc Vivo represents a substantial design change with the ''ProDisc family'' that eliminates the need of opening of the anterior cortex and reduces HO rates. Although such prostheses types with less invasive implantanchoring can have higher risks of implant dislocation, this occurred only in 3% of cases for the ProDisc Vivo and hence only marginally more often than described for keel devices.
Even if the anticipated profit of cTDR in the sense of a reduced incidence of adjacent segment disease is still in a controversial discussion, at least a correct and sufficient movement of the cTDR is a crucial requirement. Thus, further developments of HO-avoiding strategies (implant design, fixation mechanism, and postoperative care) are essential.
In the short-term FU, the key to clinical success and improvement of the outcome parameters especially in radicular arm pain is certainly the basic operative technique of sufficient decompression of the neural structures instead of the total disc prosthesis itself. Obviously, a correct placement of the prosthesis and a steady low rate of implantrelated complications is a prerequisite of sustainable good clinical outcomes, which should be verified in further studies with longer FU durations.
Key Points
The new ProDisc Vivo cervical disc arthoplasty provides significant improvement of the clinical outcome scores.
A less invasive anchoring mechanism without keels provides sufficient primary stability until the 2-year follow-up. Less invasive anchoring mechanism without the need of opening of cortical bone could reduce the incidence of heterotopic ossifications.
